Table 7.  Neurological and urogenital adverse reactions observed per number of treatments.
Adverse reaction  Studies  Total treatments, n  Adverse reactions observed, n (%)  (min%–max%) †
Neurological
   Headache  [ 39, 51]  86  40 (47)  (6 - 73) [ 39] - [ 51]
Urogenital
   Urethral irritation  [ 73]  151  110 (73)
†Incidences of the adverse reactions have been calculated for all the individual studies. (%, min-max) are the lowest and highest observed incidence of an adverse reaction observed in the group of studies included.